These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 26935632

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J, Foucar K.
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prognostic factors in myelodysplastic and myeloproliferative types of chronic myelomonocytic leukemia: a retrospective analysis of 83 patients from a single institution.
    Breccia M, Latagliata R, Mengarelli A, Biondo F, Mandelli F, Alimena G.
    Haematologica; 2004 Jul; 89(7):866-8. PubMed ID: 15257942
    [Abstract] [Full Text] [Related]

  • 28. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.
    Patnaik MM, Tefferi A.
    Am J Hematol; 2024 Jun; 99(6):1142-1165. PubMed ID: 38450850
    [Abstract] [Full Text] [Related]

  • 29. Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features.
    Calvo X, Garcia-Gisbert N, Parraga I, Gibert J, Florensa L, Andrade-Campos M, Merchan B, Garcia-Avila S, Montesdeoca S, Fernández-Rodríguez C, Salido M, Puiggros A, Espinet B, Colomo L, Roman-Bravo D, Bellosillo B, Ferrer A, Arenillas L.
    Blood Adv; 2020 Oct 27; 4(20):5285-5296. PubMed ID: 33108455
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features.
    Palomo L, Garcia O, Arnan M, Xicoy B, Fuster F, Cabezón M, Coll R, Ademà V, Grau J, Jiménez MJ, Pomares H, Marcé S, Mallo M, Millá F, Alonso E, Sureda A, Gallardo D, Feliu E, Ribera JM, Solé F, Zamora L.
    Oncotarget; 2016 Aug 30; 7(35):57021-57035. PubMed ID: 27486981
    [Abstract] [Full Text] [Related]

  • 32. How I diagnose and treat chronic myelomonocytic leukemia.
    Patnaik MM.
    Haematologica; 2022 Jul 01; 107(7):1503-1517. PubMed ID: 35236051
    [Abstract] [Full Text] [Related]

  • 33. The 2016 WHO versus 2008 WHO Criteria for the Diagnosis of Chronic Myelomonocytic Leukemia.
    Moon Y, Kim MH, Kim HR, Ahn JY, Huh J, Huh JY, Han JH, Park JS, Cho SR.
    Ann Lab Med; 2018 Sep 01; 38(5):481-483. PubMed ID: 29797820
    [Abstract] [Full Text] [Related]

  • 34. Current management of patients with chronic myelomonocytic leukemia.
    Mora E, Sanz GF.
    Curr Opin Oncol; 2018 Nov 01; 30(6):409-417. PubMed ID: 30169461
    [Abstract] [Full Text] [Related]

  • 35. Chronic myelomonocytic leukemia - a review.
    Thomopoulos TP, Bouhla A, Papageorgiou SG, Pappa V.
    Expert Rev Hematol; 2021 Jan 01; 14(1):59-77. PubMed ID: 33275852
    [Abstract] [Full Text] [Related]

  • 36. CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
    Guastafierro V, Ubezio M, Manes N, Milanesi C, Della Porta M, Bonometti A.
    Leuk Lymphoma; 2023 Sep 01; 64(9):1566-1573. PubMed ID: 37395413
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.
    Patnaik MM, Tefferi A.
    Am J Hematol; 2018 Jun 01; 93(6):824-840. PubMed ID: 29878489
    [Abstract] [Full Text] [Related]

  • 39. Recent Updates on Chronic Myelomonocytic Leukemia.
    Loghavi S, Khoury JD.
    Curr Hematol Malig Rep; 2018 Dec 01; 13(6):446-454. PubMed ID: 30311069
    [Abstract] [Full Text] [Related]

  • 40. [MDS & CMML: Diagnostic and classification].
    Wagner-Ballon O, Kosmider O.
    Bull Cancer; 2023 Nov 01; 110(11):1106-1115. PubMed ID: 37453834
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.